CF Foundation Responds to Final Short-Term, Limited-Duration Health Insurance Rule

Yesterday, the U.S. Department of Health and Human Services finalized a rule expanding short-term, limited-duration insurance plans -- threatening access to adequate, affordable coverage for people with cystic fibrosis who rely on the individual marketplace.

| 2 min read

The Cystic Fibrosis Foundation has joined 26 patient groups to express disappointment over the administration's decision to extend the maximum availability of short-term insurance plans from 90 days to up to three years. These plans will begin to be sold as soon as Sept. 30.

Short-term insurance plans were originally meant to fill a need for individuals in need of temporary insurance, such as during a transition between jobs, as opposed to providing long-term, comprehensive coverage. These plans jeopardize access to adequate, affordable health coverage on the individual marketplace by:

  • Dividing the individual insurance market into plans for healthy people and plans for sick people, driving up costs for those who need comprehensive insurance through the insurance marketplaces
  • Exempting these plans from complying with critical consumer protections, which means insurers can impose lifetime and annual caps on coverage; exclude essential health benefits; and charge people with pre-existing conditions, like CF, higher premiums or deny them coverage completely

In April, the U.S. Department of Health and Human Services (HHS) solicited public comments on the rule. One out of every three comments submitted was from the CF community, showcasing the concern from our community members.

Now that the proposed rule is final, states may take action to mitigate the impact of the short-term rule on their insurance market. As states consider proposals to alleviate the potential harm caused by this rule, we will work with lawmakers to ensure that new policies meet the needs of people with CF.

To stay informed and get involved about the Foundation's advocacy work, text “FIGHTCF” to 52886 or sign up for the Foundation's advoca­­cy alerts.

Share this article
Topics
Health Care Reform | Our Advocacy Work | Insurance
Recent news
Cystic Fibrosis Foundation Invests an Additional $5 Million in BiomX
News | 2 min read
Cystic Fibrosis Foundation Invests More Than $6.6 Million in Additional Funding in Sionna Therapeutics
News | 2 min read
Bruce Marshall, Chief Medical Officer, to Retire From the CF Foundation
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe